| Literature DB >> 31685845 |
Mareike Gastl1,2,3, Alexander Gotschy1,2, Malgorzata Polacin4, Valery Vishnevskiy2, Dominik Meyer1, Justyna Sokolska1,5, Felix C Tanner1, Hatem Alkadhi4, Sebastian Kozerke2, Robert Manka6,7,8.
Abstract
Clinical presentation of left ventricular non-compaction cardiomyopathy (LVNC) can be heterogeneous from asymptomatic expression to congestive heart failure. Deformation indices assessed by cardiovascular magnetic resonance (CMR) can determine subclinical alterations of myocardial function and have been reported to be more sensitive to functional changes than ejection fraction. The objective of the present study was to investigate the determinants of myocardial deformation indices in patients with LVNC. Twenty patients with LVNC (44.7 ± 14.0 years) and twenty age- and gender-matched controls (49.1 ± 12.4 years) underwent functional CMR imaging using an ECG-triggered steady state-free-precession sequence (SSFP). Deformation indices derived with a feature tracking algorithm were calculated including end-systolic global longitudinal strain (GLS), circumferential strain (GCS), longitudinal and circumferential strain rate (SRll and SRcc). Twist and rotation were determined using an in-house developed post-processing pipeline. Global deformation indices (GLS, GCS, SRll and SRcc) were significantly lower in patients with LVNC compared to healthy controls (all, p < 0.01), especially for midventricular and apical regions. Apical rotation and twist were impaired for LVNC (p = 0.007 and p = 0.012), but basal rotation was preserved. Deformation indices of strain, strain rate and twist correlated well with parameters of the non-compacted myocardium, but not with the total myocardial mass or the thinning of the compacted myocardium, e.g. r = 0.595 between GLS and the non-compacted mass (p < 0.001). In conclusion, CMR deformation indices are reduced in patients with LVNC especially in affected midventricular and apical slices. The impairment of all strain and twist parameters correlates well with the extent of non-compacted myocardium.Entities:
Mesh:
Year: 2019 PMID: 31685845 PMCID: PMC6828801 DOI: 10.1038/s41598-019-52161-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Segmentation of endocardial (red) and epicardial (blue) boarders as well as the non-compacted mass (green) for the calculation of masses and function in a control (A) and in a patient with LVNC (B). ch, chamber; LVNC, left ventricular non-compaction; sSA, single short axis.
Demographic characteristics of the study cohort
| LVNC (n = 20) | Controls (n = 20) | p-value | |
|---|---|---|---|
| Age (years) | 44.7 ± 14.0 | 49.1 ± 12.4 | 0.253 |
| Male (%) | 11 (55) | 13 (65) | 0.518 |
| BSA (m2) | 1.8 ± 0.2 | 1.9 ± 0.2 | 0.068 |
|
| |||
| Diabetes, n(%) | 1 (5) | 1 (5) | 1.000 |
| Hypertension, n(%) | 3 (15) | 0 (0) | 0.072 |
| Hypercholesterolemia, n(%) | 0 (0) | 0 (0) | 1.000 |
| Renal failure (CKD > II), n(%) | 0 (0) | 0 (0) | 1.000 |
| CAD, n(%) | 0 (0) | 0 (0) | 1.000 |
| Previous PCI, n(%) | 0 (0) | 0 (0) | 1.000 |
| Previous CABG n(%) | 0 (0) | 0 (0) | 1.000 |
| Previous Stroke, n(%) | 1 (5) | 0 (0) | 0.311 |
| NYHA III n(%) | 2 (10) | 0 (0) | 0.147 |
| Family history LVNC, n (%) | 7 (35) | 0 (0) | 0.004 |
BSA, body surface area; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKD, chronic kidney disease; LVNC, left-ventricular non-compaction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention.
CMR characteristics of LVNC patients and their controls.
| Left ventricle | LVNC | Controls | p-value |
|---|---|---|---|
| LV-EF [%] | 51.6 ± 8.6 | 62.1 ± 4.2 | < 0.001 |
| LVEDV [ml] | 181.1 ± 63.1 | 152.1 ± 19.9 | 0.081 |
| LV-C [mm] | 5.4 ± 1.0 | 6.2 ± 1.0 | 0.014 |
| LV-NC [mm] | 14.6 ± 5.4 | 8.1 ± 2.2 | < 0.001 |
| LV-NC/C | 2.8 ± 1.5 | 1.4 ± 0.3 | < 0.001 |
| LVMi-C [g/m2] | 55.8 ± 15.3 | 52.9 ± 11.3 | 0.779 |
| LVMi-NC [g/m2] | 39.8 ± 24.9 | 11.9 ± 3.8 | < 0.001 |
| LVMi-MM [g/m2] | 95.6 ± 33.1 | 64.8 ± 13.5 | < 0.001 |
| LVMi-NC/MM | 0.40 ± 0.10 | 0.18 ± 0.04 | < 0.001 |
|
| |||
| RV-EF | 53.8 ± 13.1 | 57.2 ± 4.9 | 0.429 |
| RVEDV | 157.5 ± 40.5 | 156.4 ± 22.9 | 0.919 |
| RV GLS | −21.8 ± 7.4 | −20.5 ± 4.9 | 0.491 |
| Free wall longitudinal | −24.4 ± 10.2 | −22.3 ± 8.6 | 0.482 |
| Septum longitudinal | −16.2 ± 6.1 | −15.0 ± 4.2 | 0.738 |
C, compacted with papillary muscles; GLS, global longitudinal strain; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVMi, left ventricular indexed mass; MM, compacted plus non-compacted, NC, non-compacted; RV, right ventricular; RVEDV, right ventricular end-diastolic volume; RVEF, right ventricular function.
Figure 2Differences of global and regional GLS [A] and GCS [B] between LVNC and controls. GCS, global circumferential strain; GLS, global longitudinal strain; LVNC, left ventricular non-compaction.
Correlation analysis between strain parameters (GLS, GCS) and left ventricular functional and dimensional parameters.
| GLS [%] | GCS [%] | |||
|---|---|---|---|---|
| R | p-value | R | p-value | |
| LVEF [%] | −0.689 | <0.001 | −0.856 | <0.001 |
| LVEDV [ml] | 0.567 | <0.001 | 0.547 | <0.001 |
| LVMi-C [g/m2] | 0.331 | 0.044 | 0.045 | 0.783 |
| LVMi-NC [g/m2] | 0.595 | <0.001 | 0.57 | <0.001 |
| LVMi-MM [g/m2] | 0.602 | <0.001 | 0.457 | 0.003 |
| LVMi-NC/MM | 0.497 | 0.001 | 0.559 | <0.001 |
| LV-C [mm] | −0.312 | 0.050 | −0.449 | 0.004 |
| LV-NC [mm] | 0.517 | 0.001 | 0.421 | 0.007 |
| LV-NC/C | 0.524 | 0.001 | 0.541 | <0.001 |
C, compacted with papillary muscles; GCS, global circumferential strain; GLS, global longitudinal strain; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVMi, left ventricular indexed mass; MM, compacted plus non-compacted, NC, non-compacted.
Intra- and interobserver reproducibility (N = 14 each) for the different deformation parameters divided by LVNC patients and healthy controls.
| Healthy | ||||||||
|---|---|---|---|---|---|---|---|---|
| Intraobserver | Interobserver | |||||||
| Mean difference ± 1.96 SD | CoV [%] | ICC (95% CI) | Mean difference ± 1.96 SD | CoV [%] | ICC (95% CI) | |||
| GLS [%] | −0.06 ± 2.86 | 6.6 | 0.97 (0.91–0.99) | −1.28 ± 4.32 | 9.6 | 0.9 (0.64–0.97) | ||
| GCS [%] | 2.32 ± 3.02 | 5.1 | 0.83 (−0.16–0.96) | 3.38 ± 4.19 | 7.2 | 0.68 (−0.24–0.92) | ||
| SRll [s−1] | −0.01 ± 0.19 | 8.2 | 0.99 (0.95–1.0) | 0.00 ± 0.266 | 11.3 | 0.98 (0.92–0.99) | ||
| SRcc [s−1] | −0.07 ± 0.16 | 4.7 | 0.98 (0.89–0.97) | −0.15 ± 0.38 | 11.5 | 0.9 (0.54–0.97) | ||
| Apical rotation [°] | −0.02 ± 0.60 | 8.4 | 0.99 (0.97–1.0) | −0.08 ± 0.82 | 11.5 | 0.98 (0.93–0.99) | ||
| Basal rotation [°] | 0.16 ± 0.54 | 12.8 | 0.99 (0.96–1.0) | 0.21 ± 0.80 | 19.3 | 0.98 (0.92–0.99) | ||
|
| ||||||||
|
|
| |||||||
|
|
|
|
|
|
| |||
| GLS [%] | −0.06 ± 2.68 | 7.2 | 0.96 (0.87–0.99) | −1.64 ± 5.35 | 13.9 | 0.77 (0.26–0.93) | ||
| GCS [%] | 1.75 ± 3.10 | 6.4 | 0.98 (0.85–1.0) | 3.1 ± 3.69 | 7.8 | 0.95 (0.09–0.99) | ||
| SRll [s−1] | −0.02 ± 0.11 | 6.4 | 0.99 (0.97–1.0) | −0.03 ± 0.24 | 14.2 | 0.95 (0.83–0.98) | ||
| SRcc [s−1] | −0.02 ± 0.13 | 5.3 | 0.99 (0.98–1.0) | −0.07 ± 0.13 | 5.4 | 0.99 (0.89–1.0) | ||
| Apical rotation [°] | −0.12 ± 0.98 | 20.2 | 0.95 (0.86–0.98) | −0.09 ± 1.04 | 21.3 | 0.95 (0.84–0.98) | ||
| Basal rotation [°] | −0.12 ± 0.42 | 13.1 | 0.99 (0.96–1.0) | −0.03 ± 0.37 | 11.8 | 0.99 (0.98–1.0) | ||
CoV, coefficient of variation; GCS, global circumferential strain; GLS, global longitudinal strain; ICC, intraclass correlation coefficient; LVNC, left ventricular non-compaction; SD, standard deviation; SRcc, peak circumferential strain rate, SR, peak longitudinal strain rate.
Figure 3Differences of global and regional SRll [A] and SRcc [B] between LVNC and controls. LVNC, left ventricular non-compaction; SR, peak-diastolic circumferential strain rate; SR, peak-diastolic longitudinal strain rate.
Correlation analysis between strain rate parameters (SRll, SRcc) and left ventricular functional and dimensional parameters.
| SRll (s−1) | SRcc (s−1) | |||
|---|---|---|---|---|
| R | p-value | R | p-value | |
| LVEF [%] | 0.546 | <0.001 | 0.756 | <0.001 |
| LVEDV [ml] | −0.472 | 0.002 | −0.486 | 0.001 |
| LVMi-C [g/m2] | −0.281 | 0.079 | −0.090 | 0.581 |
| LVMi-NC [g/m2] | −0.467 | 0.002 | −0.532 | <0.001 |
| LVMi-MM [g/m2] | −0.486 | 0.001 | −0.449 | 0.004 |
| LVMi-NC/MM | −0.395 | 0.012 | −0.542 | <0.001 |
| LV-C [mm] | 0.027 | 0.868 | 0.259 | 0.107 |
| LV-NC [mm] | −0.491 | 0.001 | −0.473 | 0.002 |
| LV-NC/C | −0.406 | 0.009 | −0.469 | 0.002 |
C, compacted with papillary muscles; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVMi, left ventricular indexed mass; MM, compacted plus non-compacted; NC, non-compacted; SRcc, peak circumferential strain rate, SR, peak longitudinal strain rate.
Figure 4Basal and apical rotation as well as end-systolic twist between LVNC and controls.LVNC, left ventricular non-compaction; rot, rotation.
Correlation analysis between twist and left ventricular functional and dimensional parameters.
| Twist [%] | ||
|---|---|---|
| R | p-value | |
| LVEF [%] | 0.615 | <0.001 |
| LVEDV [ml] | −0.247 | 0.125 |
| LVMi-C [g/m2] | 0.018 | 0.914 |
| LVMi-NC [g/m2] | −0.407 | 0.009 |
| LVMi-MM [g/m2] | −0.304 | 0.057 |
| LVMi-NC/MM | −0.443 | 0.004 |
| LV-C [mm] | 0.213 | 0.187 |
| LV-NC [mm] | −0.402 | 0.010 |
| LV-NC/C | −0.454 | 0.003 |
C, compacted with papillary muscles; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVMi, left ventricular indexed mass; MM, compacted plus non-compacted; NC, non-compacted.